Both in Diagnostics
Neogen vs Celldex Therapeutics
Over the past year NEOG returned +145.4% and CLDX returned +20.2%; their daily moves had a correlation of 0.07.
NEOG +145.4% CLDX +20.2%Growth of $1, one year, split-adjusted
| Metric | NEOG | CLDX |
|---|---|---|
| Price | $13.72 | $31.49 |
| Market cap | $2.99B | $2.47B |
| Today | −0.29% | +1.25% |
| 1 month | +16.9% | −22.2% |
| 6 months | +57.7% | +3.9% |
| Year to date | +96.3% | +15.9% |
| 1 year | +156.0% | +24.7% |
| Revenue growth (YoY) | −0.1% | −97.0% |
| Gross margin | 47.8% | 100.0% |
| Net margin | −5.0% | −334104.5% |
| P/E (TTM) | — | — |
| Price / sales | 3.4× | 15,651.2× |
| Net cash | -$619.2M | $717.6M |
| Dividend yield | — | — |
| Volatility (60d) | 52.3% | 47.6% |
| Short % of float | 5.1% | 12.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).